Edgewise Therapeutics Inc...

22.05
-1.22 (-5.24%)
At close: Mar 31, 2025, 3:59 PM
22.16
0.52%
After-hours: Mar 31, 2025, 05:12 PM EDT

Edgewise Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -18.44 -6.96 -31.12 -17.95 -86.58 -155.65
PEG Ratio 2.41 -0.02 0.47 -0.13 -1.03 n/a
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 5.37 2.19 1.38 2.76 -44.18 -87.61
P/FCF Ratio -22.36 -7.14 -8.24 -22.13 -99.52 -157.9
P/OCF Ratio -22.63 -7.58 -9.1 -22.57 -100.9 -161
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.01 0.02 0.01 n/a -4.79 -2.39
Quick Ratio 19.93 19.50 21.22 26.69 29.86 21.24
Current Ratio 19.93 19.50 21.22 26.69 29.86 21.24
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a -5.5 n/a n/a n/a
Return on Equity (ROE) -0.29 -0.31 -0.04 -0.15 0.51 0.56
Return on Assets (ROA) -0.27 -0.29 -0.04 -0.15 -0.13 -0.39
Return on Capital (ROIC) -0.34 -0.35 -0.06 -0.16 -0.14 -0.42
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a